When an infection occurs, an antibiotic may be required to quickly and effectively treat the infection. But sometimes certain infections may be unusually complicated to treat. This is when the quinolone class of antibiotics may be the best choice. There are several different types of antibiotics that may be used for various infections, but quinolones (also known as fluoroquinolones) are a type of infectious disease medication used primarily when there is a concern for multidrug resistance from other antibiotics. In the chart below, there is information regarding common quinolones antibiotics, coupons for these medications, and their safety information for review.
Drug name | Learn more | See SingleCare price |
---|---|---|
Baxdela | baxdela details | baxdela price |
Cipro | cipro details | cipro price |
Ofloxacin | ofloxacin details | ofloxacin price |
Levaquin | levaquin details | levaquin price |
Gatifloxacin | gatifloxacin details | gatifloxacin price |
Vigamox | vigamox details | vigamox price |
Moxifloxacin Hcl | moxifloxacin-hcl details | moxifloxacin-hcl price |
Avelox (moxifloxacin)
Cipro IV (ciprofloxacin)
Cipro XR (ciprofloxacin)
Penetrex (enoxacin)
Factive (gemifloxacin)
Maxaquin (lomefloxacin)
Proquin XR (ciprofloxacin)
Trovan (trovafloxacin)
Quinolones are a type of antibiotic used to help fight against various bacteria. Because of their inhibition of several different types of microorganisms, they are considered broad-spectrum antibiotics. They appear to be quite effective against gram-negative bacteria, especially Escherichia coli (E. coli) and Pseudomonas aeruginosa.
There are quite a number of side effects associated with these antibiotics, so there has been guidance provided regarding its use by the U.S. Food and Drug Administration (FDA). Because of their potential adverse effects, they are not recommended for most common infections as less toxic antibiotics may be more suitable. Therefore, they are usually set aside for more serious, complicated infections that traditional antibiotics have not been successful against. They are also an excellent alternative when there may be an allergy to traditional antimicrobial agents such as penicillin or macrolide options—especially in pneumonia cases.
As with most antibiotics, the popularity of these medications has made quinolone resistance a huge concern and threatens its clinical effectiveness. E. coli is one of the most common pathogens seen with hospital-acquired bacterial resistance.
The theory behind quinolone or fluoroquinolone resistance is for a variety of reasons. One example is related to an alteration in the DNA gyrase found in bacteria that the quinolone antibiotic usually targets. This variation in the DNA makes the antibiotic less effective against bacteria that has the capability of making these adjustments.
Another theory is that some bacteria have been able to decrease their outer membrane permeability, causing the antibiotic not to be able to appropriately destroy or inhibit the cell wall of those bacteria as the antibiotic cannot penetrate the wall as effectively as before. Finally, some bacteria have had the ability to develop efflux pumps. These pumps have the capability of allowing bacteria to survive in the presence of antibiotics, which makes certain types of antibiotics ineffective.
Luckily, most E. coli antimicrobial resistance is harmless but close attention should always occur when prescribing quinolones. Alternative forms, like cephalosporins, may need to be considered that have less likelihood for this type of resistance.
Quinolone antibiotics are known to work against different bacteria by stopping their ability to grow and infect the cells in the body. This occurs by working against two different enzymes found in bacteria. The enzymes are topoisomerase IV and DNA gyrase. Both interfere with the synthesis of DNA replication. The quinolone antibiotics that work against topoisomerase IV are more effective against gram-positive microorganisms. Whereas, the quinolone antimicrobial agents that work against DNA gyrase are more effective against gram-negative bacteria. Fluoroquinolone antibiotics are a newer derivative of quinolones, and they are capable of antibacterial activity against both topoisomerase IV and DNA gyrase simultaneously. The newer fluoroquinolones also differ in the way they are absorbed, metabolized, and excreted in the body when compared to traditional quinolones.
There are a variety of illnesses that quinolones are effective against. They include:
Anthrax treatment and prevention
Bacteremia
Bacterial infection
Bladder infection and prophylaxis
Bone infection
Bronchiectasis
Campylobacter gastroenteritis
Cervicitis
Chancroid
Cholera
Cutaneous bacillus anthracis
Epididymitis, non-specific and sexually transmitted
Febrile neutropenia
Granuloma inguinale
Infection prophylaxis
Intraabdominal infection
Joint infection
Leprosy, borderline and lepromatous
Meningococcal meningitis prophylaxis
Methicillin-resistant staphylococcus aureus (MRSA) infection
Mycobacterium avium-intracellulare, treatment
Nongonococcal urethritis
Pelvic infections
Peritonitis
Plague treatment and prophylaxis
Pouchitis
Prostatitis
Rabbit Fever
Shigellosis
Skin or soft tissue infection
Surgical prophylaxis
Transurethral prostatectomy
Traveler’s diarrhea
Typhoid fever
First-generation quinolone antibacterial agents are some of the first in their class but are rarely used today. These antibacterial agents are inhibitors against gram-negative bacteria except there is no susceptibility for Pseudomonas species.
Uncomplicated urinary tract infections are most commonly treated with this type of antibiotic. They are unfortunately prone to antibiotic resistance of many bacteria and should be avoided in those individuals with poor renal function.
Examples of first-generation quinolone antibiotics: Negram, Cinobac
Second-generation quinolone antibiotics are also effective against gram-negative bacteria like first-generation antibiotics. They also have susceptibility against Pseudomonas species. In addition, they possess some gram-positive bacteria coverage like Staphylococcus aureus—but not Streptococcus pneumoniae.
These antibiotics are also useful with treatment against uncomplicated and complicated urinary tract infections, pyelonephritis, sexually transmitted diseases, prostatitis, bone infections, and skin/soft tissue infections.
Examples of second-generation quinolone antibiotics: Cipro, Floxin, Maxaquin
Third-generation antibiotics have an even more extensive spectrum of activity against bacteria than the first two generations. They include the same coverage as generation two quinolones but also have more susceptibility against gram-positive organisms such as penicillin-sensitive S. pneumoniae or penicillin-resistant S. pneumoniae. There is also expanded activity against atypical pathogens (Mycoplasma pneumoniae and Chlamydia pneumoniae).
The newer versions also allow for daily or twice daily dosing, decreasing the frequency of taking the medication. These more modern forms of quinolones also have the pharmacokinetics to treat lower respiratory tract infections that were not available with previous options. Various types of infections can be treated including all of the previous conditions mentioned previously along with chronic bronchitis and community-acquired pneumonia.
Examples of third-generation quinolone antibiotics: Avelox, Levaquin, Tequin
Fourth-generation quinolones have the most coverage against various bacteria of all the quinolone generations as it has the best tissue penetrations. Streptococcus pneumoniae and Pseudomonas are included in this class, but they also have the capability to fight against anaerobic bacteria.
Unfortunately, they also have the most serious potential complications and side effects with their use. Due to this, they are usually limited for use of life- and limb-threatening infections. It is also restricted or recommended that it should be taken for no longer than 14 days.
It has extensive coverage against many medical conditions including all of the first three generations’ illnesses but also intra-abdominal infections, nosocomial pneumonia, and pelvic infections. They do not effectively treat complicated urinary tract infections or pyelonephritis.
Examples of fourth-generation quinolone antibiotics: Trovan
Overall, quinolones are considered safe options to treat a variety of different types of pathogens for both men and women.
Quinolone antibiotics should never be the first line of treatment as there are other less toxic options especially in those who are pregnant or breastfeeding. Quinolones can be used if needed during pregnancy, but the risks versus benefits should strongly be accessed by your healthcare provider. There is some data that shows concern for spontaneous abortion or damage to bone or cartilage to the unborn child with use in quinolone antibiotics. Also, quinolones are not recommended while breastfeeding as there is a concern for infant gastrointestinal complications.
Quinolones are not recommended in children up to 18 unless it is serious resistant strains of pathogens that first-line antibiotics have not been successful with treating. Children are believed to be more susceptible to developing adverse effects associated with quinolone antibiotics. They usually include gastrointestinal complications but there is also a more serious concern for damage to weight-bearing joints.
Seniors, patients on long-term steroid therapy, or organ transplant patients may want to avoid quinolones as they are at higher risk for developing tendon ruptures, peripheral neuropathy, or central nervous system implications.
When prescribing these medications, a licensed healthcare professional will need to be aware of the several known complications and various drug interactions associated with these antimicrobial agents to prescribe safely.
Recalls
KRS Global Biotechnology, Inc. issues voluntary nationwide recall, September 2019
Altaire Pharmaceuticals, Inc. issues voluntary recall of multiple ophthalmic products, July 2019
Promise Pharmacy issues voluntary nationwide recall of prednisolone and gatifloxacin ophthalmic solution, October 2018
AuroMedics Pharma LLC issues voluntary nationwide recall of levofloxacin, January 2018
Do not use quinolones if you have:
Hypersensitivity to medication
History of cardiac disease particularly problems with the QT interval
History of high blood pressure
Marfan syndrome
Myasthenia gravis
Ehlers-Danlos syndrome
60 years of age or older
Risk of or prior history of aortic aneurysm
Irregularities with electrolytes
Quinolones antibiotics are not a controlled substance as there is no risk of dependency from the use of these medications.
There are a variety of common side effects seen with quinolone use. Some complications to be on the lookout for include:
Nausea
Diarrhea
Vomiting
Abdominal pain
Headache
Indigestion
Dizziness
Restlessness
Lightheadedness
Vaginitis
Insomnia
Reaction to the sun
Itching
Rash
Anxiety
Agitation
Confusion
Tendinitis
Joint pain
Elevated liver enzymes
Muscle pain
Disorientation
Problems with focusing
Nervousness
Impaired memory
Delirium
Paranoia
Hallucinations
Nightmares
Tremor
Low blood sugars
More severe adverse effects include:
Hypersensitivity reaction
Acute severe allergic reaction
Severe skin reaction
Vasculitis
Inflammation of lungs
Serum sickness
Phototoxicity
C. difficile associated diarrhea
Superinfection
Seizures
Increased intracranial pressures
Toxic psychosis
Depression
Suicidality
QT prolongation in the heart
Torsades de pointes
Renal toxicity
Crystals in urine
Liver toxicity
Decreased bone marrow
Blood disease
Peripheral neuropathy
Tendon rupture
Myasthenia gravis exacerbation
Aortic aneurysm
Aortic dissection
RELATED: Ciprofloxacin side effects and how to avoid them
Although the antibacterial quinolones are not a first-line antibiotic therapy for many bacteria, these antibiotics are quite commonly prescribed by healthcare providers. They tend to be more expensive than first-line antibiotics especially when treating simple infections. If you are required to take a quinolone antibiotic, it may cost $100 to $2,000 for a prescription. If you need to use these types of antibiotics, consider using free SingleCare coupons to help reduce costs.
Marquissa Beverly, DPM, MHA, graduated from Barry University School of Podiatric Medicine. She completed her three-year surgical training of the foot and ankle at South Miami Hospital. Dr. Beverly has 12 years of clinical and surgical experience in the lower extremity. She lives in the Tampa Bay area with her family, where she works in private practice. Her passion is patient advocacy through education so that people may be active participants in their own health care. As a medical writer and reviewer, Dr. Beverly feels this allows her to reach more people to help them live healthier lives.
...Health education, drug info, wellness & more
Prescription savings vary by prescription and by pharmacy, and may reach up to 80% off cash price. This is a medical discount plan. This is NOT insurance. This program offers you the opportunity to locate providers of various types of medical services who will offer their services to you at discounted rates. The range of discounts for medical or ancillary services provided under the plan will vary depending on the type of provider and service received. You are fully responsible for paying for all health care services but will be entitled to receive a discount from those health care providers in accordance with the specific pre-negotiated discounted fee schedule. This program does not guarantee the quality of the services or procedures offered by the providers. Except for prescription drugs which you will pay directly to the pharmacy at the time of purchase, all other services received through a program provider will be charged to the credit card on file in your member account. The charge will include an administrative fee for use of the program. Towers Administrators LLC is the licensed discount medical plan organization with its administrative office located at 4510 Cox Road, Suite 111, Glen Allen, VA 23060. SingleCare Services, LLC is the marketer of the discount medical plan organization including its website, singlecare.com, with its corporate office located at 99 High Street, Suite 2800, Boston, MA 02110. For additional information, including an up-to-date list of providers, or assistance with any issue related to program membership, please contact member support any time at www.singlecare.com, or by calling toll-free 844-234-3057, 24 hours, 7 days a week (except major holidays). Pharmacy names, logos, brands, and other trademarks are the property of their respective owners.
© 2025 SingleCare Administrators. All rights reserved
© 2025 SingleCare Administrators. All rights reserved